Purpose: Innate immunity and dysregulation of inflammatory processes play a role in vascular diseases like atherosclerosis or diabetes. Nucleotide-binding domain and Leucine-rich repeat Receptor containing a Pyrin domain 3 (NLRP3) inflammasomes are pro-inflammatory signalling complexes that were found in 2002. In addition to pathogens and other extracellular threats, they can be activated by various endogenous danger signals. The purpose of this study was to find out whether NLRP3 activation occurs in patients with sight-threatening forms of diabetic retinopathy (DR). Methods: Inflammasome components NLRP3 and caspase-1, inflammasomerelated pro-inflammatory cytokines IL-1b and IL-18, vascular endothelial growth factor (VEGF), acute-phase cytokines TNF-a and IL-6, as well as adaptive immunity-related cytokine interferon gamma (IFN-c) were measured from the vitreous samples of 15 non-proliferative diabetic retinopathy (non-PDR) and 23 proliferative diabetic retinopathy (PDR) patients using the enzyme-linked immunosorbent assay (ELISA) method. The adaptor protein apoptosis-associated speck-like protein containing a CARD (ASC) was determined using the Western blot technique. Results: Inflammasome components were present in the vitreous of DR patients. Along with VEGF, the levels of caspase-1 and IL-18 were significantly increased, especially in PDR eyes. Interestingly, clearly higher levels of NLRP3 were found in the PDR eyes with tractional retinal detachment (TRD) than from PDR eyes with fully attached retina. There were no significant differences in the amounts of IL-1b, TNF-a, IL-6, and IFN-c that were detectable in the vitreous of both non-PDR and PDR patients. Conclusion: Our results suggest that NLRP3 inflammasome activation can be associated especially with the pathogenesis of PDR. The lack of differences in TNF-a, IL-6, and IFN-c also alludes that acute inflammation or T-cell-mediated responses do not dominate in PDR pathogenesis.
Introduction
Diabetic retinopathy (DR) is a multifactorial disease with a complex interplay of microvascular, neurodegenerative, genetic/epigenetic, immunological, and inflammation-related factors. According to the level of microvascular degeneration and ischaemic damage, DR can be classified into non-PDR and PDR, the latter of which is characterized by pathological angiogenesis coupled with fibrotic responses at the vitreoretinal interface (Stitt et al. 2016 ). This remodelling process also involves contribution from inflammatory and pro-angiogenic macrophages, leading to the activation of wound-healing response, formation of severe fibrosis (gliosis), and breakdown of blood-retinal barrier (Schr€ oder et al. 1991; Friedlander 2007; Loukovaara et al. 2015c) .
Inflammasomes are large cytosolic protein complexes composed of intracellular pattern recognition receptors (PRRs), adaptor proteins, and caspase enzymes (Martinon et al. 2009 ), resulting in the release of proinflammatory cytokines of IL-1b and IL-18. In the best-characterized inflammasome, NLRP3 serves as the receptor protein.
Aberrant inflammasome activation has been associated with several diseases and disorders. Direct links between NLRP3 inflammasome activation and pathogenesis are visible, e.g. in gout, atherosclerosis, pulmonary fibrosis, sunburns, and contact hypersensitivity, where NLRP3 becomes activated by monosodium urate (MSU) crystals, asbestos, nanoparticles, or silica, UVB irradiation, and skin irritants, respectively (Martinon et al. 2006; Watanabe et al. 2007; Dostert et al. 2008; Yazdi et al. 2010; Hiramoto et al. 2012 ). In addition, inflammasomes are known to play a role in multifactorial diseases including age-related macular degeneration (AMD), Alzheimer's disease, Parkinson's disease, and multiple sclerosis, as well as metabolic disorders, such as obesity and type 2 diabetes Stienstra et al. 2010; Menu & Vince 2011; Doyle et al. 2012; Kauppinen et al. 2012; Tarallo et al. 2012; Codolo et al. 2013; Heneka et al. 2013 ). In the retina, oxidized lipoproteins and free radicals are considered major causes of tissue stress and serve as local triggers for retinal inflammation (Xu et al. 2009 (Xu et al. , 2015 . Extended exposure to stress factors together with disturbed control mechanisms results in chronic inflammation that maintains pathological conditions and contributes to disease progression (Kowluru & Chan 2007; Devi et al. 2012; Loukovaara et al. 2014 Loukovaara et al. , 2015a Loukovaara et al. , 2016 .
Materials and Methods

Diabetic subjects
Originally, a total of 40 diabetic patients of Caucasian origin were recruited to this prospective and clinicopathologic study in the unit of vitreoretinal diseases at the Helsinki University Hospital (HUH) Eye Clinic during the years 2010-2013. All patients underwent preoperatively a proper eye examination by the recruiting vitreoretinal eye surgeon. The eye examination included measurements of visual acuity (VA), intraocular pressure (IOP), and axial length (AL), as well as slit-lamp biomicroscopic and funduscopic examinations. Indications for primary diabetic vitrectomy were (i) active PDR with or without TRD threatening or involving the macula, (ii) severe non-clearing vitreous haemorrhage (VH) >2 months, or (iii) diabetic macular oedema (DME) with or without vitreous traction (Loukovaara et al. 2013) .
Vitreous samples of 40 eyes from 40 diabetic patients were analysed. Two diabetic patients were excluded from the final analysis; one because of congenital cataract and another due to previous renal transplantation and concomitant immunosuppression treatment. In all, 15 eyes suffering from non-PDR and 23 from PDR were included in the final analysis. In the eyes of PDR, perfused neovessels were observed on the retinal vascular arcades neovessel along temporal retinal arcade (NVE) or at the optic disc during vitrectomy neovessel at optic disc (NVD). Five patients from non-PDR group had received intravitreal anti-vascular endothelial growth factor (VEGF; bevacizumab, Avastin, Genentech, Inc., San Francisco, CA, USA) treatment prior to surgery. One of these patients received one anti-VEGF injection, and four patients had received three separate injections without a centre-involving DME resolution ( Table 1 ). The study was conducted according to the principles of the Declaration of Helsinki, and it was approved by the Institutional Review Board of Helsinki University Central Hospital and the Ethical committee. A signed informed consent was obtained from each participant before insertion in the study.
All spectral domain optical coherence tomography (SD-OCT) examinations were performed with an Optovue RTVue V.5.1 device (Optovue Inc, Fremont, CA, USA) using a standardized macular protocol. The scan pattern used on Optovue RTVue was retina MM6, which gives accurate thickness measurements in fovea, perifovea (<3 mm), and parafovea (<6 mm). The measurements of central retinal thickness in the innermost foveal area were recorded and analysed pre-and postoperatively. All study subjects were assessed by the same vitreoretinal surgeon with an RTVue optical coherence tomography (OCT) device using MM6 macular scan protocol under mydriatic circumstances. Macular thickness measurements obtained by OCT were considered to be an important objective source of information to detect and follow morphologic retinal pathological changes, including DME (serous retinal detachment, cystic changes, retinal swelling), epiretinal fibrosis, and PDR.
Surgery and vitreous sample collection
Diabetic eyes underwent a 23-gauge standard three-port pars plana vitrectomy using the CONSTELLATION Vision System (Alcon Laboratories, Inc., Fort Worth, TX, USA) without an infusion of artificial fluid. The samples were collected by manual aspiration into a syringe via the vitrectomy with the cutting function activated. Samples were transferred into sterile 1.5-ml Eppendorf tubes (Freemont, CA, USA) and immediately frozen at À70°C until laboratory analyses.
Protein measurement
Total protein concentrations (mg/ml) in vitreous samples were measured using a bicinchoninic acid (BCA) protein assay kit (Pierce, Thermo Scientific) according to the manufacturer's instructions. To minimize interfering factors, e.g. blood-derived iron, each sample was diluted 1:30 and 1:50 in sterile water before the measurement.
Enzyme-linked immunosorbent assay (ELISA) measurements
A multiplex ELISA (Meso Scale Discovery, Rockville, MD, USA) was used for determining TNF-a, IL-6, and IFN-c, from vitreous samples according to the manufacturer's instructions. Due to sensitivity issues, IL-1b was measured using a specific OptEIA TM set (BD Pharmingen, Franklin Lakes, NJ, USA). Moreover, IL-18 (Platinum ELISA Kit, eBioscience, San Diego, CA, USA), NLRP3 (Cusabio, Wuhan, China), and VEGF (R&D Systems, Abingdon, UK) were measured according to manufacturer's instructions. For detecting IL-18 and VEGF, three and six samples, respectively, were pooled in equal amounts.
Western blot
For detecting ASC from vitreous samples, 30 lg of protein in vitreous fluids was treated with the hyaluronidase enzyme (2 mg/ml; Sigma-Aldrich, St. Louis, MO, USA) for 10 min in room temperature (RT). Thereafter, the samples were mixed with a protein loading solution (Life Technologies, Carlsbad, CA, USA) supplemented with 5% bmercaptoethanol (Sigma-Aldrich), run in 15% SDS-PAGE gels, and wetblotted overnight onto nitrocellulose membranes. The membranes were blocked for 2 hr in 5% fat-free milk in 0.1% Tween-20/Tris-buffered saline (TBS; 50 mM Tris, 150 mM NaCl) at RT. The blocking buffer without milk served as a washing buffer and as a diluent to primary and secondary antibodies. After washing, membranes were incubated overnight at +4°C with antihuman rabbit polyclonal ASC antibody (both 1:1000; Enzo Life Sciences, Farmingdale, NY, USA). After washing three times for 5 min, membranes were incubated for 1 hr at RT with horseradish peroxidase-conjugated anti-rabbit IgG antibody (1:5000; Novex by Life Technologies). Before detection, membranes were washed as mentioned above. Protein-antibody complexes were detected with the enhanced chemiluminescent (ECL) assay for horseradish peroxidase (Millipore, Billerica, MA, USA) on Super Rx medical X-ray film (Fuji Corporation, Tokyo, Japan). The band intensities were quantified using the ImageJ software (US National Institutes of Health, Bethesda, MD, USA; http://rsb.info.nih.gov/ij) and normalized to b-actin values using mouse monoclonal b-actin (1:4000; Santa Cruz Biotech, Dallas, TX, USA) and polyclonal HRP-conjugated sheep antimouse IgG (GE Healthcare, Fairfield, CT, USA) antibodies.
Statistical analyses
Statistical analyses were performed using the IBM SPSS Statistics System 22 (IBM, Armonk, NY, USA). Independent-samples t-test was used between group comparisons. Equality of variances was tested by Levene's test. Fisher's exact test was used for qualitative data for two-group comparisons. p-values of 0.05 or less were considered significant.
Results
Clinical characteristics of diabetic subjects
Main systemic and ocular characteristics of the study patients assigned to non-PDR and PDR groups are given in Table 1 . Noteworthy, PDR patients were significantly younger than the non-PDR patients (p < 0.001). Otherwise, there were no significant differences in gender, duration of diabetes, American Society of Anesthesiologists (ASA) classification, glycated haemoglobin (>8% in both groups), smoking, body mass index (>27.5 in both groups), blood pressure (systolic/diastolic), or previous laser treatment between the two study groups.
In the PDR group, all patients except six had type 1 diabetes, whereas majority of non-PDR patients had type 2 diabetes (p < 0.001). Additionally, VH and TRD occurred more commonly in PDR than in non-PDR eyes (p ≤ 0.001). As measured by SD-OCT, no difference between the study groups occurred in the numbers of patients suffering from DME (p = 0.52). Eighteen eyes of 23 (78.3%) in the PDR group had active perfused neovessel formation located at the optic disc (NVD; Table 1 ).
Inflammasome markers are present especially in the vitreous of PDR patients
The levels of caspase-1 and IL-18 were significantly higher in the PDR eyes when compared to non-PDR vitreous fluids (p < 0.0001 and p < 0.001, respectively; Table 2 ). The findings are comparable with VEGF whose levels were also significantly higher in the vitreous fluids of PDR patients than in non-PDR samples (356.82 AE 145.66 versus 57.99 AE 34.08 pg/ml, respectively; p < 0.0001). In addition to inflammasome markers and VEGF, acute-phase cytokines TNF-a and IL-6, as well as Tcell-derived macrophage activator IFNc were measured, and no differences were visible between non-PDR and PDR patients in those markers (Table 2) .
Non-PDR subgroup analysis
Five patients in the non-PDR group had received anti-VEGF treatment (bevacizumab) for reducing DME prior to the primary diabetic vitrectomy. In the anti-VEGF-treated non-PDR eyes, the levels of VEGF were lower than in non-treated non-PDR eyes (22.67 AE 0.0 versus 78.17 AE 25.1 lg/ll, p < 0.05). Also, caspase-1 levels were significantly lower in the eyes treated with bevacizumab (p < 0.05). 
PDR subgroup analysis
When analysing PDR eyes according to TRD, we found significantly higher levels of NLRP3 (p < 0.05) in the eyes with TRD (n = 13) when compared to PDR eyes with fully attached retina (n = 10; Table 3 ). When taking into account previous immunohistochemical analyses (Loukovaara et al. 2015b ), PDR eyes with most fulminant neovessel formation at the optic disc or along the temporal arcades had higher levels of NLRP3 (p = 0.029) and IL-18 (p = 0.026) than PDR eyes with inactive neovessel formation (Table 4) . Additionally, intravitreal levels of NLRP3 were significantly higher (p = 0.026) in those PDR eyes where epiretinal membrane (ERM) peeling was needed (n = 15) when compared to eyes where ERM was not found and no peeling was performed (n = 8). In these eyes, there was a tendency towards higher levels of IL-6 (p = 0.068).
Discussion
Inflammation is assumed to be involved in the development of DR, especially in the formation of pathological neovascularization occurring in PDR (Zhou et al. 2012; Loukovaara et al. 2015b,c) . In agreement with previous studies, the major pro-inflammatory cytokines IL-6, TNF-a, and IFN-c could be detected both in non-PDR and in PDR eyes (Yoshimura et al. 2009 ). There were no differences between two DR disease severity forms, as also seen previously (Loukovaara et al. 2015c) . In the present study, we also found traces of NLRP3 inflammasome activation in the vitreous fluid samples of DR patients. Interestingly, levels of the executing caspase-1 and the inflammasome-related cytokine IL-18 were increased, especially in the eyes of PDR patients. This finding suggests that the NLRP3 inflammasome signalling may constitute a novel mechanism for PDR pathogenesis (Qi et al. 2014) . Significantly higher levels of NLRP3 were found in the PDR eyes with TRD than in PDR eyes with fully attached retina. Moreover, PDR eyes with most fulminant and active neovessel formation at the optic disc and/or along temporal arcades had higher levels of NLRP3 than those PDR eyes with Concentrations (mean AE SD) are shown as pg/ml. Independent-samples t-test was used for group comparisons, and the equality of variances was tested using the Levene's test. Results were considered statistically significant at p ≤ 0.05 (bold). ASC = apoptosis-associated speck-like protein containing a CARD, IFN-c = interferon gamma, IL = interleukin, TNF-a = tumour necrosis factor alpha, NLRP3 = nucleotide-binding domain and leucine-rich repeat receptor containing a pyrin domain 3, VEGF = vascular endothelial growth factor, PDR = proliferative diabetic retinopathy. Concentrations (mean AE SD) are shown as pg/ml. Independent-samples t-test was used for group comparisons, and the equality of variances was tested using the Levene's test. Results were considered statistically significant at p ≤ 0.05 (bold). ASC = apoptosis-associated speck-like protein containing a CARD, IFN-c = interferon gamma, IL = interleukin, TNF-a = tumour necrosis factor alpha, NLRP3 = nucleotide-binding domain and leucine-rich repeat receptor containing a pyrin domain 3, VEGF = vascular endothelial growth factor, TRD = tractional retinal detachment. Concentrations (mean AESD) are shown as pg/ml. Independent-samples t-test was used for group comparisons, and the equality of variances was tested using the Levene's test. Results were considered statistically significant at p ≤ 0.05 (bold). ASC = apoptosis-associated speck-like protein containing a CARD, IFN-c = interferon gamma, IL = interleukin, TNF-a = tumour necrosis factor alpha, NLRP3 = nucleotide-binding domain and leucine-rich repeat receptor containing a pyrin domain 3, VEGF = vascular endothelial growth factor.
inactive neovessel formation. This finding suggests that inflammasome activation plays a role in the most severely perfused forms of DR. Nod-like receptor pyrin domain containing protein 3 inflammasome has been linked to the tissue fibrosis process (Robert et al. 2016) . The role of inflammasome activation in PDR is supported by our results from non-PDR patients where caspase-1 levels were significantly lower in the eyes treated with the anti-VEGF product bevacizumab than in untreated ones. Despite the rather small study population, increased levels of caspase-1 and IL-18 can be considered correct instead of a random coincidence or artefact because differences were prominent and in line with the result with VEGF measured from vitreous samples. Due to strong neovascularization, it is probable that increased VEGF levels are detectable in the eyes of PDR patients. Our findings are in accordance with another study where IL-18 and VEGF levels were higher in the vitreous fluids of PDR patients than in those of non-diabetic controls (Song et al. 2014) . The pathogenesis of DR has been under studies for decades but still not yet not fully understood. A number of working hypotheses have replaced each other over the years to explain the disease development. Although our present study describes the presence of the inflammatory marker NLRP3 in increasing concentrations in the vitreous fluid of patients with PDR and even higher concentrations in those with TRD, our results may still be hampered by some methodological limitations. The measured concentrations of the compounds in the vitreous were not compared with the levels of these markers in the plasma. This is of importance, because an increased vitreous content of a compound might be due to the leakage over the blood-retinal barrier so that one actually measures a barrier dysfunction. Secondly, the findings might be due to the contamination of the vitreous aspirate with blood, which is the likely, the more advanced retinopathy is being operated on. Noteworthy, local factors, i.e. profiles of inflammation-related cytokines present in the vitreous fluid, may reflect better the actual pathological alterations in the retinal micro milieu. Increased pro-inflammatory factors in patients with PDR may originate, for example, from ischaemic and/or hypoxic retinal endothelial cells, glial cells, or injured neurons. In addition to endogenous danger signals like extracellular ATP, DR pathology includes several ROS-producing processes, such as glucose auto-oxidation, polyol pathway activation, protein glycation, and the formation of advanced glycation end products (AGEs), which are capable of inducing the NLRP3 inflammasome signalling (Wolff & Dean 1987; Brownlee et al. 1988; Medzhitov 2008; Zhou et al. 2011; Gombault et al. 2013) . Despite various potential sources and clear pathology, the overall levels of proinflammatory markers remain very low, especially in chronic conditions, predisposing them to rapid dilution and disappearance. In our previous studies, we have measured intravitreal ATP and ADP (Loukovaara et al. 2013 ) as well as both intravitreal and plasma ATP and ADP (Loukovaara et al. 2016 ). According to those data, intravitreal ATP levels were significantly higher in the vitreous samples of PDR eyes when compared to non-PDR eyes (Loukovaara et al. 2013 (Loukovaara et al. , 2016 , whereas no difference was observed in the plasma samples (Loukovaara et al. 2016) . Thereby, we demonstrated selective diabetes-related increases in ATP concentrations in the vitreous fluid but not in the plasma (Loukovaara et al. 2016) .
With regard to the concern about passive leakage due to broken bloodretinal barrier, NLRP3 is an inducible PRR (O'Connor et al. 2003 ) whose increased expression can therefore be related to enhanced pro-inflammatory state. We have observed the inducibility of NLRP3 also in human RPE cells (Piippo et al. 2014) . Similarly, we have seen that NLRP3 becomes secreted from the cell following its activation (N Piippo, E Korhonen, M Hytti, H Skottman, K Kinnunen, G Petrovski, K Kaarniranta, and A Kauppinen, unpublished observations), which is in line with published findings (Martinon et al. 2002; Martinon & Tschopp 2004) . The secretion of inflammasome components along with the cytokines is considered to prevent apoptosis (Martinon & Tschopp 2004; Mariathasan et al. 2004; Feldmeyer, 2007) .
In conclusion, our present findings support the active role of NLRP3 inflammasome, especially in sightthreatening PDR. Anti-VEGF therapy reduced the levels of caspase-1 in the vitreous of non-PDR patients, suggesting that inflammasome activation also participates in non-PDR and additionally supports the link between inflammasome and VEGF. The highest levels of NLRP3 were observed in the eyes suffering from the most severe forms of PDR, such as TRD and fulminant perfused neovessel formation. Moreover, significantly higher levels of IL-18 were detected in the PDR eyes when compared to non-PDR vitreous samples. In addition to severity and neovascularization, our data allude that IL-18 could contribute to type 1 diabetes, whereas IL-1b might associate merely with type 2 diabetes and early phases of DR. These aspects would be worth of examining in more detail in subsequent studies.
